Viracta TherapeuticsVIRX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 38 institutions reported holding Viracta Therapeutics Inc. (VIRX) in their 13F filings, down 2 from Q2 2024. 10 opened new positions and 10 sold out. The largest holders were Citadel Advisors ($352K), Vanguard Group Inc. ($220K) and Samsara Biocapital, LLC ($160K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Viracta Therapeutics Inc.
- CUSIP
- 92765F108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $185K |
| Exits | 10 | $2.1M |
All 13F filers, Q2 2024 → Q3 2024: 864,244 shares bought and 4,250,658 shares sold, net −3,386,414 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Citadel Advisors | 0.00% | No change | 1,520,240 | $352K |
| Vanguard Group Inc. | 0.00% | Reduce -17.8% | 954,485 | $220K |
| Samsara Biocapital, LLC | 0.03% | No change | 689,709 | $160K |
| Stonepine Capital Management, LLC | 0.07% | New | 500,000 | $116K |
| Laurion Capital Management LP | 0.01% | Reduce -18.4% | 332,189 | $77K |
| Aisling Capital Management LP | 0.03% | No change | 288,571 | $66K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.7% | 250,007 | $58K |
| Renaissance Technologies | 0.00% | Add +12.7% | 245,399 | $57K |
| BlackRock, Inc. | 0.00% | — | 234,846 | $54K |
| HRT Financial LP | 0.00% | New | 138,822 | $32K |
| Landscape Capital Management, L.L.C. | 0.00% | New | 68,317 | $16K |
| State Street Corp. | 0.00% | No change | 65,867 | $15K |
| United Capital Financial Advisors, LLC | 0.00% | New | 42,995 | $10K |
| Northern Trust Corp. | 0.00% | No change | 38,104 | $9K |
| Morgan Stanley | 0.00% | Reduce -77.2% | 30,669 | $7K |
| Goldman Sachs Group Inc. | 0.00% | New | 27,090 | $6K |
| Inspirion Wealth Advisors, LLC | 0.00% | Add +66.7% | 25,000 | $6K |
| Royal Bank of Canada | 0.00% | Add +4276.4% | 20,000 | $5K |
| WealthTrust Axiom LLC | 0.00% | Add +43.9% | 16,396 | $4K |
| Bank of America Corp. | 0.00% | Add +20.5% | 15,054 | $3K |
| Focus Partners Wealth | 0.00% | New | 14,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +9.6% | 13,870 | $3K |
| Trust Co. of Toledo NA | 0.00% | No change | 12,317 | $3K |
| XTX Topco Ltd | 0.00% | Reduce -47.0% | 10,174 | $2K |
| Acadian Asset Management LLC | 0.00% | No change | 10,908 | $2K |
| Planning Capital Management Corp | 0.00% | No change | 7,272 | $2K |
| Dunhill Financial, LLC | 0.00% | New | 5,000 | $1K |
| RP Management, LLC | 0.00% | No change | 3,700 | $851 |
| IAG Wealth Partners, LLC | 0.00% | No change | 3,000 | $694 |
| Oarsman Capital, Inc. | 0.00% | New | 1,000 | $231 |
| Jones Financial Companies LLLP | 0.00% | New | 1,000 | $222 |
| JPMorgan Chase & Co. | 0.00% | No change | 721 | $167 |
| Indiana Trust & Investment Management Co | 0.00% | No change | 200 | $46 |
| Wells Fargo & Company | 0.00% | No change | 171 | $40 |
| UBS Group AG | 0.00% | Reduce -94.4% | 95 | $22 |
| Parallel Advisors, LLC | 0.00% | No change | 8 | $2 |
| Addison Advisors LLC | 0.00% | No change | 4 | $1 |
| Planned Solutions, Inc. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is VIRX's weight in each manager's 13F, not the share of Viracta Therapeutics Inc. the manager owns.